Revisiting Age Criterion for Surgery in Asymptomatic Primary Hyperparathyroidism

Area of Science:

• Endocrinology
• Surgical Oncology
• Health Economics

Background:

• Asymptomatic primary hyperparathyroidism (PHPT) management guidelines often cite age 50 as a surgical candidacy criterion.
• The optimal age for surgical intervention in PHPT remains a subject of ongoing clinical debate.
• Evidence-based recommendations for surgical intervention in asymptomatic PHPT are crucial for patient care.

Purpose of the Study:

• To evaluate the cost-effectiveness and benefits of parathyroidectomy (PTX) versus observation in asymptomatic PHPT patients.
• To determine if the current age criterion of 50 years for surgical candidacy in PHPT is optimal.

Main Methods:

• A Markov model was developed using data from PubMed, Embase, Medline, and Google Scholar.
• The model compared parathyroidectomy (PTX) and observation strategies for asymptomatic PHPT.
• Quality-adjusted life year (QALY) gains were calculated via sensitivity and Monte-Carlo simulations.

Main Results:

• The PTX strategy yielded a higher QALY (19.17) compared to observation (17.82).
• Significant incremental QALY gains for PTX were observed across various age groups, including 2.2 QALY for 50-year-olds and 1.35 QALY for 60-year-olds.
• Incremental QALY gains remained positive beyond age 75, though diminishing.

Conclusions:

• Parathyroidectomy (PTX) is a beneficial treatment for asymptomatic PHPT patients, including those over the age of 50.
• The study supports surgical intervention for medically fit patients in their 50s.
• Current guidelines for surgical treatment of asymptomatic PHPT should be reconsidered.